Could fighting brain inflammation slow Alzheimer's?
NCT ID NCT04795466
Summary
This study aimed to see if anti-inflammatory drugs could help slow cognitive decline in people with early Alzheimer's disease or mild memory problems due to Alzheimer's. It tested one drug in a small group of participants over 20 weeks, measuring changes in memory, thinking skills, and brain inflammation. The trial was terminated early, so only one drug was studied in a limited number of people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
-
Novartis Investigative Site
Kuopio, 70210, Finland
-
Novartis Investigative Site
Turku, 20520, Finland
-
Novartis Investigative Site
Reykjavik, 101, Iceland
-
Novartis Investigative Site
Plymouth, Devon, PL6 8BT, United Kingdom
-
Novartis Investigative Site
Guildford, Surrey, GU27YD, United Kingdom
-
Novartis Investigative Site
London, W1G 9JF, United Kingdom
-
Novartis Investigative Site
Motherwell, ML1 4UF, United Kingdom
-
Novartis Investigative Site
Southampton, SO30 3JB, United Kingdom
-
SUNY at Stony Brook
Stony Brook, New York, 11794-8161, United States
Conditions
Explore the condition pages connected to this study.